Effect of Sampling Method and Storage Conditions on Albumin,Retinol-Binding Protein,And N-Acetyl-β-D-Glucosaminidase Concentrations in Canine Urine Samples

Abstract

Urinary markers for renal dysfunction are gaining interest, but effects of sampling method, storage conditions, and urinary tract inflammation or infection on these markers are unclear. Therefore, the objectives of the current study were to determine the difference in urinary albumin (uALB), urinary retinol-binding protein (uRBP), and urinary N-acetyl-β-D-glucosaminidase (uNAG) concentrations in cystocentesis and voided samples and to investigate concentration changes after storage at −20°C and at −80°C. Effects of a protease inhibitor were also assessed in samples stored at −80°C for 12 months. In a pilot experiment, influence of in vitro hematuria, pyuria, and bacteriuria on the urinary markers was evaluated. A mixed model was used to calculate mean differences and 95% confidence intervals. Urinary ALB, uNAG, and uRBP concentrations were similar in voided and cystocentesis samples. After storage for 4 months at −20°C, uALB concentration was not affected, and uRBP concentration showed a mild and clinically irrelevant decrease, whereas uNAG activity was significantly lower compared with fresh samples. After storage for 12 months at −80°C, uALB and uRBP concentrations did not differ from fresh samples, but uNAG activity was severely decreased. Protease inhibitor addition did not preserve uNAG activity. Experimental hematuria, pyuria, and bacteriuria did not seem to affect urinary markers, although further research is needed.

Keywords

Albumin N-acetyl-β-D-glucosaminidase retinol-binding protein storage;urine

Introduction

Early diagnosis of decreased kidney function remains a challenge in veterinary medicine because of limitations of current diagnostic tests. Traditional diagnostic markers such as blood urea nitrogen and serum creatinine will only be increased when already 75% of functional renal mass is lost. 8 Measurement of glomerular filtration rate is a more sensitive technique but usually requires labor-intensive and time-consuming clearance tests. 32 Therefore, novel urinary markers that have demonstrated their potential for early and site-specific detection of renal dysfunction in human studies are gaining interest in companion animal medicine. 15,21,24,27 Among others, these urinary markers include intermediate weight proteins such as albumin (ALB), low molecular weight proteins such as retinol-binding protein (RBP), and urinary enzymes such as N-acetyl-β-D-glucosaminidase (NAG). Glomerular dysfunction causes increased filtration of albumin, whereas tubular dysfunction leads to excessive urinary excretion of RBP and NAG due to disturbed reabsorption or structural damage of tubule cells, respectively. 10 These markers may not only allow early diagnosis of primary renal disease, they are also able to detect subclinical renal dysfunction secondary to infectious or endocrine disorders (e.g., pyometra, leishmaniasis, hyperthyroidism, and Cushing's disease). 9,12,20,31

In order to perform reliable clinical studies using urinary markers, urine samples need to be collected and stored in optimal conditions to preserve protein integrity and enzyme activity. Studies evaluating the effect of sampling method and storage conditions on determination of urinary markers are lacking in veterinary medicine and therefore mandatory.

Hence, the first objective of the current study was to determine whether urinary (u)ALB, uRBP, and uNAG concentrations differ between samples collected by cystocentesis or by free catch. The second aim was to investigate whether urinary marker concentrations decrease over time depending on storage duration and freezing temperature and if a protease inhibitor (PI) cocktail preserves protein concentrations in samples stored at −80°C for 12 months. In a pilot experiment, effects of in vitro hematuria, pyuria, and bacteriuria on urinary marker concentrations were assessed.

Material and methods

Urine samples

The present study was performed at the Faculty of Veterinary Medicine, Ghent University (Merelbeke, Belgium), after approval by the Local Ethical Committee. Eleven privately owned dogs were included (2 neutered males, 5 intact females, and 4 spayed females), diseased as well as healthy, to ensure a broad range of urinary marker concentrations. The study group consisted of 3 healthy dogs, 1 dog with diabetes mellitus, 1 dog with combined diabetes mellitus and Cushing's disease, 1 dog with Cushing's disease, and 5 dogs with chronic kidney disease. Immediately after morning urine samples were obtained by ultrasound-guided cystocentesis, dogs were walked, and a voided urine sample was collected from each dog. During cystocentesis, care was taken to avoid peripheral blood contamination, and none of the samples showed macroscopic discoloration possibly leading to falsely increased urinary albumin concentrations. 29 After centrifugation (3 min, 447 × g), a complete urinalysis (dipstick, a urine specific gravity, urine protein-to-creatinine ratio, sediment analysis, and bacterial culture) was done on cystocentesis samples. Dipstick and sediment analyses of the voided samples were also performed. The remaining supernatant was divided into aliquots of 0.5 ml and frozen at −20°C and −80°C. Sufficient aliquots were frozen to avoid multiple freeze—thaw cycles during future analyses. Fifty microliters of PI cocktail b was added to 1 ml of cystocentesis and voided urine, and 4 aliquots of each were frozen at −80°C. One aliquot of both cystocentesis and voided samples was used immediately for measurement of uALB, uRBP, and uNAG in fresh samples.

Analysis of urinary markers

Urinary ALB, uRBP, and uNAG concentrations were measured in cystocentesis and voided samples within 3 hr after collection (time 0: T₀) and after 4 months of storage at −20°C (time 4 months: T_{4 months}). Furthermore, urinary markers were determined in cystocentesis samples after 12 months of storage at −20°C and at −80°C (time 12 months: T_{12 months}) and in PI samples stored at −80°C. Urinary ALB concentration was determined with a commercial canine-specific sandwich enzyme-linked immunosorbent assay (ELISA) kit, c uRBP with a human ELISA kit, d and uNAG activity using a colorimetric assay, e as previously validated and described. 15,27 Mean interassay coefficient of variation was 12.0% for uALB analysis, 8.5% for uRBP, and 8.1% for uNAG. 15,27

Effect of hematuria, pyuria, and bacteriuria

Cystocentesis urine samples of 2 healthy dogs were used to evaluate the effect of experimental hematuria, pyuria, and bacteriuria on uALB, uRBP, and uNAG concentrations. A heparinized blood sample of 1 healthy dog was used to mimic hematuria and to isolate white blood cells. Whole blood was diluted 4,000- and 16,000-fold in the urine samples, yielding a 3+ and 1+ hematuria on dipstick analysis, f respectively. Furthermore, white blood cells were isolated after gradient centrifugation on Percoll. g , 28 Briefly, 2 ml of blood was layered carefully on Percoll with a density of 1.077. The tube was centrifuged at 340 × g for 30 min at room temperature. Then plasma was discarded, and the opaque band containing the white blood cells at the interface between plasma and the Percoll layer was aspirated with a Pasteur pipette and transferred into a conical tube. After 3 washing steps in a phosphate buffered saline solution, the white blood cells were counted. h Cytospin preparations i were stained j and showed isolated white blood cells to consist mainly of neutrophils (74%) and further of lymphocytes (21%) and monocytes (5%). White blood cells were added to the urine samples until a final concentration of approximately 80 white blood cells per μl was obtained, corresponding with 1+ pyuria on dipstick analysis.

For the bacteriuria experiment, Escherichia coli bacteria were grown overnight, and bacterial concentration was determined using a standard curve plotting the colony forming units (CFUs) as a function of the absorbance at 550 nm. Bacteria were diluted in the urine samples until a final concentration of 10⁵ CFU per ml was obtained.

All urine samples (i.e., 1+ and 3+ hematuria, 1+ pyuria, and bacteriuria) and blank urine samples were incubated at 38°C for 2 hr to simulate a retention period in the bladder at body temperature. After centrifugation (3 min at 447 × g), the supernatant was divided into aliquots of 1 ml and stored at −80°C until analysis within 2 weeks. Additionally, blank urine samples without incubation at 38°C were also centrifuged and stored at −80°C as negative controls. Urinary ALB, uRBP, and uNAG concentrations were compared between blank samples and hematuria, pyuria, and bacteriuria samples of the 2 dogs to assess the effect of red blood cell, white blood cell, and bacterial contamination.

Statistical analysis

Analyses were performed with a commercial software program k using a mixed model with dog as random effect, and with collection method, storage time, freezing temperature, and addition of PI as categorical fixed effects. Urinary ALB, uRBP, and uNAG concentrations were compared between cystocentesis and voided samples at T₀ and at T_{4 months}. Urinary marker concentrations at T_{4 months} and T_{12 months} were compared with concentrations at T₀. At T_{12 months}, uALB, uRBP, and uNAG concentrations in samples stored at −80°C with and without PI were compared with each other and with T₀ samples. All tests were performed at 5% significance level.

Mean differences between sampling techniques, storage time, and temperature with 95% confidence intervals (CIs) were derived. Equivalence between sampling techniques or between storage conditions can be claimed when the CI is contained in a region of differences, which is considered to be clinically irrelevant. To calculate the mean percentage change of uALB, uRBP, and uNAG over time, a simple regression analysis was performed with difference at 2 time points as response variable and the value at earliest time point as covariate.

Results

There was no statistically significant difference in uALB, uRBP, and uNAG concentrations between cystocentesis and voided urine samples at T₀ or T_{4 months} (P > 0.05). Mean differences between cystocentesis and voided samples at T₀ and T_{4 months} are presented in Figure 1.

Differences in uALB, uRBP, and uNAG concentrations after storage at −20°C and −80°C are also shown in Figure 1. At T_{4 months} after storage at −20°C, uALB concentration was not significantly different from T₀ (P > 0.05), with a mean difference of 29.96 mg/l (95% CI: [−18.55; 51.48]). Urinary RBP concentration was significantly but mildly decreased (P = 0.02), with a mean difference of 40.11 μg/l (95% CI: [12.51; 67.71]). Urinary NAG activity was significantly lower compared with T₀, with a mean decrease of 0.61 U/l (95% CI: [0.27; 0.95]; P = 0.005). Mean percentage decrease ± standard error (SE) was 15% ± 3% for uRBP and 20% ± 11% for uNAG, respectively.

At T_{12 months} after storage at −20°C, uALB and uNAG concentrations were significantly lower than at T₀ (P = 0.006 and P < 0.0001, respectively). Mean difference was 99.83 mg/l (95% CI: [44.25; 155.4]) and 2.87 U/l (95% CI: [2.13; 3.6]) for uALB and uNAG, respectively. For uALB, mean percentage decrease ± SE was 20% ± 6% and for uNAG 92% ± 4%. Urinary RBP was not significantly different compared with T₀ (P > 0.05), with a mean difference of 37.92 μg/l (95% CI: [−2.13; 77.97]).

At T_{12 months} after storage at −80°C, only uNAG activity showed a significant decrease of 2.7 U/l (95% CI: [2.09; 3.3]) compared with T₀ (P < 0.0001), with a mean decrease of 89% ± 5%. Urinary ALB and uRBP concentrations did not differ significantly from T₀ (P > 0.05), with a difference of 42.89 mg/l (95% CI: [−15.33; 101.1]) and 7.3 μg/l (95% CI: [−4.84; 19.44]), respectively.

Samples with addition of PI were analyzed only at T_{12 months} after storage at −80°C. Urinary ALB, uRBP, and uNAG concentrations were not statistically different in samples with PI compared with samples stored without PI (P > 0.05). Urinary NAG activity remained significantly lower compared with T₀ (P < 0.0001), regardless of PI addition.

As presented in Table 1, uALB, uRBP, and uNAG concentrations did not differ between blank samples and urine samples with 1+ hematuria, 1+ pyuria, and bacteriuria. Urinary ALB and uRBP, but not uNAG concentration, showed a very mild increase in samples with 3+ hematuria.

Discussion

Results of the present study demonstrate that uALB, uRBP, and uNAG concentrations do not differ significantly between cystocentesis and voided urine samples. In contrast, storage conditions may affect uALB and uRBP concentrations and uNAG enzyme activity. Results also suggest that the addition of a PI cocktail does not preserve uNAG activity after long-term storage at −80°C. Effects of experimental microscopic hematuria, pyuria, and bacteriuria on these urinary marker concentrations seem to be minimal, although these in vitro results do not reflect the complexity of an inflammatory process in vivo, and further research is needed.

In human medicine, there are many reports on urine sample storage conditions, their effect on protein concentrations and on subsequent data interpretation. 4,11,16,17,26 To the authors' knowledge, the effect of sampling method on urinary marker concentrations has never been reported in dogs or cats. In reports on uALB, uRBP, or uNAG in canine or feline urine, cystocentesis as well as catheterization and midstream voided urine have been used. 12,19,30 In contrast to voided samples, cystocentesis avoids contamination with lower urinary tract epithelial cells, proteases, and bacteria that may affect urinary markers. 22 When performing cystocentesis, care must be taken to avoid peripheral blood contamination leading to grossly discolored urine samples, since this may cause a falsely increased urinary albumin concentration. 29 However, results of the present study did not indicate a statistically significant difference in uALB, uRBP, or uNAG concentrations between cystocentesis and voided samples at T₀ and at T_{4 months} after storage at −20°C. Despite this general finding, 1 dog with combined diabetes mellitus and Cushing's disease, and a negative urine culture, had increased uALB, uRBP, and uNAG concentrations in the voided sample (voided: uALB, 183.17 mg/l; uRBP, 71.1 μg/l; uNAG, 5.86 U/l; cystocentesis: uALB, 33 mg/l; uRBP, 29.8 μg/l; uNAG, 1.51 U/l). In this male castrated dog, macroscopic hematuria was not present in either the cystocentesis or voided sample. Sediment analysis of the cystocentesis sample did not reveal pyuria or inflammation. However, in the sediment of the voided sample, increased amounts of red blood cells, white blood cells, and epithelial cells were detected. Therefore, one hypothesis might be that urethral inflammation or preputial disease caused severe contamination of the urine sample, which affected the urinary markers. This finding suggests that other components of the inflammatory response, not mimicked by the in vitro experiment, may also play a role. Although, in general, a significant difference between cystocentesis and voided samples was not detected, possible inter-individual variations should be considered.

Figure 1.

Mean differences in (A) urinary albumin (uALB), (B) urinary retinol-binding protein (uRBP), and (C) urinary N-acetyl-β-D-glucosaminidase (uNAG) concentrations between cystocentesis and voided samples in fresh urine and after storage for 4 months at −20°C, and between fresh urine samples and samples stored at −20°C and at −80°C for 4 and 12 months.

Table 1.

Urinary marker concentrations in blank urine samples and urine samples with experimental hematuria, pyuria, and bacteriuria. *

	Dog 1			Dog 2
	uALB (mg/l)	uRBP (μg/l)	uNAG (U/l)	uALB (mg/l)	uRBP (μg/l)	uNAG (U/l)
Blank samples
0 hr incubation	25.9	161.6	1.8	2.9	BDL	BDL
2 hr incubation at 38°C	34.2	163.7	1.4	3.5	BDL	BDL
Hematuria
RBC 1+	34.1	183.7	1.9	3.4	BDL	BDL
RBC 3+	40.5	217.1	1.9	8.1	58.3	BDL
Pyuria 1+	35.7	160.9	2.1	3.6	BDL	BDL
Bacteriuria	34.9	164.4	1.9	4.4	BDL	BDL

uALB = urinary albumin; uRBP = urinary retinol-binding protein; uNAG = urinary N-acetyl-β-D-glucosaminidase; BDL = below detection limit; RBC = red blood cells.

To the authors' knowledge, there are no reports in the veterinary literature on stability of uRBP, uALB, and uNAG after frozen storage. At T_{4 months} after storage at −20°C, uALB concentration was comparable with T₀. In human medicine, there are contradictory reports on uALB stability. Results of the present study are in agreement with previous studies that describe no significant change in uALB concentration after storage at −20°C for up to 6 months. 3,7 However, others detected a decrease of 20% in uALB concentration after 6 months at −20°C. 26 In the present study, uRBP was significantly lower at T_{4 months} compared with T₀. Nevertheless, this decrease was mild (40.11 μg/l), and the entire 95% CI was within a clinically acceptable range. Moreover, the RBP ELISA range of analytical variation for canine urine is 15.6% (mean interassay coefficient of variation + 2× standard deviation) and mean percentage decrease of uRBP reported herein was 15%. 15 Therefore, the decrease in uRBP may be due to assay variation. Urinary NAG was significantly lower at T_{4 months} compared with T₀, with a mean percentage decrease of 20%. This finding corresponds to results of studies in human medicine, which demonstrated a 25.6% decrease in uNAG after 2 months of storage at −20°C. 2

While both uALB concentration and uNAG activity were significantly decreased at T_{12 months} after storage at −20°C, only uNAG was significantly lower compared with T₀ after storage at −80°C. For uALB, these findings are similar to previous results demonstrating a significant decline in human uALB after 12 months at −20°C, but not at −80°C. 11 In the present study, uNAG was dramatically decreased at T_{12 months} with losses of 92% at −20°C and of 89% at −80°C. Addition of a PI cocktail had no effect on the preservation of uNAG. The decrease at −80°C was unexpected because studies in human medicine indicated a largely preserved uNAG activity (84.6%) after storage for 12 months at −70°C. 17 Still, components of canine urine differ from human urine, and enzyme activities are influenced by many factors, such as temperature, pH, specific inhibitors, creatinine, urea, and electrolytes. 13 Alkaline pH (>8) causes a rapid decrease of uNAG, but urinary pH values in the present study ranged from 5.5 to 8, and only 1 sample had a pH of 8. 13,18

At T_{12 months} after storage at −20°C, uRBP was not significantly lower compared with T₀. This may seem contradictory because uRBP was mildly decreased at T_{4 months}. However, the former decline is probably due to assay variability, and none of the observed differences is so large as to have clinical relevance. In the current study, storage at −20°C for 4–12 months seems to have only minimal effects on uRBP concentration. This finding is in contradiction with results obtained from human samples demonstrating decreased uRBP concentrations after storage at −20°C for 6–8 months. However, it must be noted that only a minority of samples in the latter study showed substantial underestimation. 26 At T_{12 months} after storage at −80°C, the present study indicated no significant difference in uRBP compared with T₀. This is in accordance with data from human medicine demonstrating no significant change in uRBP when stored at −70°C for 8 months. 26

Guidelines advise diagnosticians to exclude urinary tract inflammation or infection (UTI) before identifying the origin of proteinuria because it influences urinary total protein-to-creatinine ratio. 1,14 However, the effect on other urinary markers is currently unclear. In human medicine, there is no evidence that asymptomatic UTI causes proteinuria or albuminuria. 6 Results of the present pilot experiment suggest that experimental pyuria, 1+ and 2+ hematuria, and bacteriuria do not affect uALB, uNAG, or uRBP concentrations. However, these findings have to be interpreted with caution because in vitro addition of leucocytes or bacteria to urine does not fully reflect an in vivo inflammatory process, with its complex interactions between stimulated leucocytes and bacteria involving inflammatory cytokines, bacterial products, and urinary molecules released from various sources. Samples with 3+ hematuria had a negligible increase in uALB and uRBP, probably caused by contamination of plasma albumin and RBP through addition of whole blood to the urine samples. These results are in agreement with previous data from canine urine samples showing no increased uALB in the majority of pyuric samples and a uALB above normal range only in macroscopically hematuric samples. 29 Two studies report similar canine uNAG activity in samples with or without hematuria, asymptomatic bacteriuria, or positive urine cultures. 5,12 One report showed increased uNAG concentration in dogs with pyelonephritis but not in dogs with lower UTI. 25 Effects of UTI on uRBP have not been reported in veterinary medicine. Data from human medicine, however, showed increased uRBP in patients with acute pyelonephritis, but not in patients with cystitis or asymptomatic bacteriuria. 23

Limitations of the present study are that data were obtained at only 3 time points (0, 4, and 12 months) in a relatively small sample group and that the effect of a PI was examined after 12 months at −80°C, but not at −20°C. The pilot experiment to assess effects of hematuria, pyuria, and bacteriuria is limited because it does not fully mimic the complexity of an in vivo cystitis. Therefore, further work is needed to evaluate the true influence of UTI on these urinary markers. The study was not designed to clarify underlying mechanisms of storage effects on the markers but provides essential information regarding storage conditions for further research in the domain of urinary markers.

In conclusion, samples for analysis of uALB and uRBP can be stored at −20°C for up to 4 months, whereas −80°C is preferred for storage up to 12 months. Urinary NAG enzyme activity is less stable at −20°C as well as −80°C, with already substantial losses after 4 months at −20°C and a more severe decline after 12 months at −80°C.

Acknowledgements

This work was funded by a grant from the “Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen.” The authors thank Kristel Demeyere for her excellent technical assistance.

Footnotes

a.

Combur stick, Roche Diagnostics, Mannheim, Germany.

b.

Calbiochem protease inhibitor cocktail set n° III, Merck KGaA, Darmstadt, Germany.

c.

Canine albumin ELISA, Immunology Consultants Laboratory, Newberg, OR.

d.

Retinol binding protein ELISA, Immundiagnostik AG, Bensheim, Germany.

e.

β-N-Acetylglucosaminidase Assay Kit, Sigma-Aldrich, St. Louis, MO.

f.

Multistix 8 SG, Bayer AG, Leverkusen, Germany.

g.

Percoll, Sigma-Aldrich, St. Louis, MO.

h.

Coulter Counter, Coulter Electronics Ltd., Buckinghamshire, England, United Kingdom.

i.

Shandon Cytospin cytocentrifuge and Shandon Cytoclip slide clips, Thermo Scientific, Runcorn, Cheshire, United Kingdom.

j.

Hemacolor, Merck KGaA, Darmstadt, Germany.

k.

SAS version 9.1, SAS Institute Inc., Cary, NC.

References

Bagley

Center

Lewis

: 1991, The effect of experimental cystitis and iatrogenic blood contamination on the urine protein creatinine ratio in the dog. J Vet Intern Med 5:66–70.

Berg

Kristoffersen

Djoseland

: 1998, Reference range of some enzymes and proteins in untimed overnight urine and their stability after freezing. Clin Chim Acta 272:225–230.

Brinkman

de Zeeuw

Duker

: 2005, Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples. Clin Chem 51:2181–2183.

Brinkman

de Zeeuw

Heerspink

HJL

: 2007, Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry. Clin Chem 53:1520–1526.

Brunker

Ponzio

Payton

: 2009, Indices of urine N-acetyl-beta-D-glucosaminidase and gamma-glutamyl trans-peptidase activities in clinically normal adult dogs. Am J Vet Res 70:297–301.

Carter

Tomson

CRV

Stevens

Lamb

: 2006, Does urinary tract infection cause proteinuria or microalbuminuria? a systematic review. Nephrol Dial Transplant 21:3031–3037.

Collins

ACG

Sethi

Macdonald

: 1993, Storage-temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia 36:993–997.

Finco

: 1995, Kidney function. In: Clinical biochemistry of domestic animals, ed. Kaneko

Harvey

Bruss

, 5th ed., pp. 441–484. Academic Press, San Diego, CA.

Forterre

Raila

Schweigert

: 2004, Protein profiling of urine from dogs with renal disease using ProteinChip analysis. J Vet Diagn Invest 16:271–277.

10.

Hart

SGE

: 2005, Assessment of renal injury in vivo. J Pharmacol Toxicol 52:30–45.

11.

Heerspink

HJL

Nauta

van der Zee

: 2009, Alkalinization of urine samples preserves albumin concentrations during prolonged frozen storage in patients with diabetes mellitus. Diabetic Med 26:556–559.

12.

Heiene

Moe

Molmen

: 2001, Calculation of urinary enzyme excretion, with renal structure and function in dogs with pyometra. Res Vet Sci 70:129–137.

13.

Jung

Pergande

Schreiber

Schroder

: 1983, Stability of enzymes in urine at 37-degrees-C. Clin Chim Acta 131:185–191.

14.

Lees

Brown

Elliott

: 2005, Assessment and management of proteinuria in dogs and cats: 2004 ACVIM Forum Consensus Statement (small animal). J Vet Intern Med 19:377–385.

15.

Maddens

BEJ

Daminet

Demeyere

: 2010, Validation of immunoassays for the candidate renal markers C-reactive protein, immunoglobulin G, thromboxane B₂ and retinol binding protein in canine urine. Vet Immunol Immunopathol 134:259–264.

16.

Mao

Chen

: 1996, Frozen storage of urine samples before ELISA measurement of retinol-binding protein. Clin Chem 42:466–467.

17.

Matteucci

Giampietro

: 1994, To store urinary enzymes—how and how long? Kidney Int 46(suppl): S58–S59.

18.

Morita

Numata

Kosugi

: 1998, Stabilities of N-acetyl-beta-D-glucosaminidase (NAG) isoenzymes in urine: Advantage of NAG isoenzyme B measurement in clinical applications. Clin Chim Acta 278:35–43.

19.

Murgier

Jakins

Bexfield

Archer

: 2009, Comparison of semiquantitative test strips, urine protein electrophoresis, and an immunoturbidimetric assay for measuring microalbuminuria in dogs. Vet Clin Pathol 38:485–492.

20.

Palacio

Liste

Gascon

: 1997, Enzymuria as an index of renal damage in canine leishmaniasis. Vet Rec 140:477–480.

21.

Price

: 2002, Early markers of nephrotoxicity. Comp Clin Pathol 11:2–7.

22.

Reusch

Vochezer

Weschta

: 1991, Enzyme activities of urinary alanine aminopeptidase (AAP) and N-acetyl-beta-D-glucosaminidase (NAG) in healthy dogs. Zentralbl Veterinarmed A 38:90–98.

23.

Sandberg

Cooper

Lidin-Janson

: 1985, Fever and proximal tubular function in acute pyelonephritis. Nephron 41:39–44.

24.

Sarasua

Mueller

Kathman

: 2003, Confirming the utility of four kidney biomarker tests in a longitudinal follow-up study. Ren Fail 25:797–817.

25.

Sato

Soeta

Miyazaki

: 2002, Clinical availability of urinary N-acetyl-beta-D-glucosaminidase index in dogs with urinary diseases. J Vet Med Sci 64:361–365.

26.

Schultz

Dalton

Turner

: 2000, Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. Diabetic Med 17:7–14.

27.

Smets

PMY

Meyer

Maddens

BEJ

: 2010, Urinary markers in healthy young and aged dogs and dogs with chronic kidney disease. J Vet Intern Med 24:65–72.

28.

Strasser

Kalmar

Niedermuller

: 1998, A simple method for the simultaneous separation of peripheral blood mononuclear and polymorphonuclear cells in the dog. Vet Immunol Immunopathol 62:29–35.

29.

Vaden

Pressler

Lappin

Jensen

: 2004, Effects of urinary tract inflammation and sample blood contamination on urine albumin and total protein concentrations in canine urine samples. Vet Clin Pathol 33:14–19.

30.

van Hoek

Daminet

Notebaert

: 2008, Immunoassay of urinary retinol binding protein as a putative renal marker in cats. J Immunol Methods 329:208–213.

31.

van Hoek

Lefebvre

Peremans

: 2009, Short-and long-term follow-up of glomerular and tubular renal markers of kidney function in hyperthyroid cats after treatment with radioiodine. Domest Anim Endocrinol 36:45–56.

32.

Watson

Lefebvre

Concordet

: 2002, Plasma exogenous creatinine clearance test in dogs: Comparison with other methods and proposed limited sampling strategy. J Vet Intern Med 16:22–33.